hapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Vaccine Adjuvants Market, by Region, 2019-2027 (USD Billion)
1.2.2. Vaccine Adjuvants Market, by Product type, 2019-2027 (USD Billion)
1.2.3. Vaccine Adjuvants Market, by Route of administration, 2019-2027 (USD Billion)
1.2.4. Vaccine Adjuvants Market, by Application, 2019-2027 (USD Billion)
1.2.5. Vaccine Adjuvants Market, By Disease type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccine Adjuvants Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccine Adjuvants Market Dynamics
3.1. Vaccine Adjuvants Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High prevalence of infectious and zoonotic diseases
3.1.1.2. Increasing focus on immunization programs from various government bodies
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory environment and time-consuming approvals
3.1.2.2. High cost of adjuvant research
3.1.3. Market Opportunities
3.1.3.1. Pandemic diseases
3.1.3.2. Combination adjuvants
Chapter 4. Global Vaccine Adjuvants Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Vaccine Adjuvants Market, by Product type
5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Product type, Performance - Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Product type 2018-2027 (USD Billion)
5.4. Vaccine Adjuvants Market , Sub Segment Analysis
5.4.1. Pathogen Components
5.4.2. Adjuvant Emulsions
5.4.3. Particulate Adjuvants
5.4.4. Combination Adjuvants
5.4.5. Others
Chapter 6. Global Vaccine Adjuvants Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Route of Administration, Performance - Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Route of administration 2018-2027 (USD Billion)
6.4. Vaccine Adjuvants Market , Sub Segment Analysis
6.4.1. Oral
6.4.2. Subcutaneous
6.4.3. Intranasal
6.4.4. Intramuscular
6.4.5. Intradermal
6.4.6. Others
Chapter 7. Global Vaccine Adjuvants Market, by Disease type
7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Disease type, Performance - Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Disease type 2018-2027 (USD Billion)
7.4. Vaccine Adjuvants Market , Sub Segment Analysis
7.4.1. Research Applications
7.4.2. Commercial Applications
Chapter 8. Global Vaccine Adjuvants Market, by Application
8.1. Market Snapshot
8.2. Global Vaccine Adjuvants Market by Application, Performance - Potential Analysis
8.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
8.4. Vaccine Adjuvants Market , Sub Segment Analysis
8.4.1. Research and Development
8.4.2. Clinical Diagnostics
Chapter 9. Global Vaccine Adjuvants Market, Regional Analysis
9.1. Vaccine Adjuvants Market , Regional Market Snapshot
9.2. North America Vaccine Adjuvants Market
9.2.1. U.S. Vaccine Adjuvants Market
9.2.1.1. Product type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027
9.2.1.3. Disease type breakdown estimates & forecasts, 2018-2027
9.2.1.4. Application breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Vaccine Adjuvants Market
9.3. Europe Vaccine Adjuvants Market Snapshot
9.3.1. U.K. Vaccine Adjuvants Market
9.3.2. Germany Vaccine Adjuvants Market
9.3.3. France Vaccine Adjuvants Market
9.3.4. Spain Vaccine Adjuvants Market
9.3.5. Italy Vaccine Adjuvants Market
9.3.6. Rest of Europe Vaccine Adjuvants Market
9.4. Asia-Pacific Vaccine Adjuvants Market Snapshot
9.4.1. China Vaccine Adjuvants Market
9.4.2. India Vaccine Adjuvants Market
9.4.3. Japan Vaccine Adjuvants Market
9.4.4. Australia Vaccine Adjuvants Market
9.4.5. South Korea Vaccine Adjuvants Market
9.4.6. Rest of Asia Pacific Vaccine Adjuvants Market
9.5. Latin America Vaccine Adjuvants Market Snapshot
9.5.1. Brazil Vaccine Adjuvants Market
9.5.2. Mexico Vaccine Adjuvants Market
9.6. Rest of The World Vaccine Adjuvants Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. SPI Pharma, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Brenntag Biosector A/S
10.2.3. Seppic
10.2.4. CSL Limited
10.2.5. Agenus, Inc.
10.2.6. Novavax, Inc.
10.2.7. Invivogen
10.2.8. SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
10.2.9. Avanti Polar Lipids, Inc.
10.2.10. MVP Laboratories, Inc.
10.2.11. OZ Biosciences
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption